MaxQ Medical Raises $31.5 Million for Prostate Care Platform
Aug 20, 2026
Funding
ABK Biomedical Raises $35 Million in Series D Funding Led by J.P. Morgan Life Sciences
Nov 12, 2025
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
ABK Biomedical has raised $35 million in an oversubscribed Series D financing round led by new investor J.P. Morgan Life Sciences Private Capital, announced in a press release. Existing investors including F-Prime, Santé Ventures, Eight Roads Ventures, and an undisclosed medical device company also participated.
The funds will support the company’s ongoing clinical operations, preparation for the commercialization of its Eye90 microspheres, and further product development. Additional capital will be used to expand manufacturing and supply chain capabilities to meet future demand.
Eye90 microspheres, which have received FDA Breakthrough Device Designation, are currently being evaluated in the Route90 FDA IDE pivotal trial. The company aims to use the proceeds to advance the trial and position the product for market readiness.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like AI Funding Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Funding
Sep 15 Decimal AI Raises $4 Million for Customer Support Engineering Platform Sep 15 Radical Ventures Secures Over $1 Billion for AI Fund Sep 15 EUCLYD Raises More Than €200 Million for AI Inference Infrastructure Sep 15 EnforceShield Raises €1.7M for Autonomous IP Enforcement Sep 15 Anthropic Expects Second Consecutive Profitable QuarterMore from Life Sciences
Sep 15 LexisNexis Adds MyChart Identity Proofing to Epic Toolbox Sep 15 Sensei Partners With Zentist for Dental EOB Automation Sep 15 MGI Tech Launches VisiOmics in Europe Sep 15 Deloitte Launches Agentforce CRM Accelerator for Life Sciences Sep 14 Inductive Bio Launches Indy Chemistry AssistantFree newsletter
Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
.png)
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read moreYou may also like
Jetstream Venture Fund Invests in ImageAiD and Moonrise Medical
Aug 27, 2026
Healthcare
Superluminal Medicines Raises $60 Million for Obesity Drug Trial
Sep 03, 2026
Funding
Pixelgen Raises $15.5 Million for Proxiome Kit Expansion
Aug 20, 2026
Funding
BrightPlan Closes First Part of Series C Round Led by ABS Capital
Sep 08, 2026
Funding
Airbility Raises $4.7 Million for AI Counter Drone Aircraft
Sep 02, 2026
Funding
Free, six days a week
Daily AI Brief: the AI news that matters, in your inbox.